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– Prince Agri Products
– Purina
– Zoetis
Vaccinating Calves: Questions 
• Can immunity of calves be improved by 
vaccination?
• How early can you vaccinate calves effectively?
• What about maternal antibody interference?
Immune Development: 
Prenatal Calf
• Immune system begins developing before calf is born
– Thymus (T cell development) evident at 40 days gestation
– Response to some viruses possible at 70 days gestation
– By third trimester, can respond to many different 
infections




• At birth, calf has no antibody in serum
– Unless infected before birth
• Other issues
– Serum complement levels lower than adults
– Cell functions lower than adults
• neutrophils
• macrophages
• antigen presenting cells
• T and B cells
• Immune response of neonatal calf is 
functional, but naïve and immature
• Colostrum is a solution to this problem
Response of calf lymphocytes to mitogenic 
(nonspecific) stimulation in first week of life 
Data from Kehrli, in Cortese 2009
• Calves vaccinated at 8 hours old were protected against 
Mycobacterium bovis challenge 15 weeks later  
Buddle et al., 2003
• Colostrum-deprived calves exposed to coronavirus at 1 
day of age were protected against challenge at 3 weeks
Heckert et al., 1991
• Calves vaccinated with ovalbumin at 2 days of age: 
antibody at 4 weeks
• Calves vaccinated with PPD at 2 days of age: skin test 
positive at 7 weeks                              Nonnecke et al., 2012
• Numerous studies show diminished immune 
responses in 1 – 2 week old calves, compared 
to juveniles or adults
• BUT:  calves within a week of life CAN mount 
meaningful immune responses
• Not clear when in first week is best time to 
vaccinate if vaccination is appropriate
Vaccination of calves and 
maternal antibody
• Vaccination in the face of maternal antibody 












Vaccination with maternal antibody
No response
Calf vaccination IFOMA
• Several studies indicate calves CAN 
respond to vaccination IFOMA
– Anamnestic response when maternal antibodies 
gone
– Measures of T cell responsiveness in absence 
of seroconversion
– Protection against later challenge
Vaccination IFOMA and antibody 
responses
• 2-3 month old beef calves 
– Vaccinated with MLV IBRV + BVDV 
• IBRV SN titers 1:19
• BVDV SN titers 1:35
• Control calves not vaccinated
• Both groups vaccinated again at 6-7 m.o.
Menanteau-Horta et al, 1985
• Calves vaccinated at 2-3 months 
seroconverted to BVDV
– IBRV titers continued to fall
• At vaccination at 6-7 months, calves 
vaccinated IFOMA seroconverted rapidly 
to IBRV
– Significantly higher titers than calves not 
vaccinated at 2-3 months
Vaccination IFOMA can prime for memory response when 
maternal antibodies are gone
Antibody 
titer
2-3 months 6-7 months
Vaccination IFOMA and antibody 
responses—inactivated vaccine
• 2 – 3 month old beef calves
IBRV SN titers: <1:2 – 1:128
BVDV 1 SN titers: 1:20 - 1:1920 
BVDV 2 SN titers: 1:7.5 - 1:1280
– Inactivated IBRV/BVDV/PI3/BRSV 
• Vira Shield® 5
• ELITE® 4
• Triangle® 4 
– Control group, no vaccine
– Boosted 1 month later Kaeberle et al, 1998
• At 6-7 months of age, calves in Vira-Shield 
group had significantly higher titers to IBRV, 
BVDV 1, and BVDV 2 than control calves
• Administration of some inactivated vaccines 
IFOMA induces persistence of serum 
antibody




Vaccination IFOMA can prolong titers
Vaccination IFOMA and antibody 
responses—effect of age
• Dairy calves vaccinated with M. haemolytica vaccine 
(Presponse®)
– 2 and 4 weeks old
– 6 and 8 weeks old
– Control group not vaccinated
• No difference in titers at 2 weeks of age
Hodgins and Shewen, 1998
• At 10 weeks of age, leukotoxin neutralizing titers 
significantly higher in calves vaccinated at 6 and 8 
weeks
– Not significantly higher in calves vaccinated at 2 
and 4 weeks
• Magnitude of titer and age may impact efficacy of 
vaccination IFOMA in very young calves
Vaccination IFOMA and T cell responses
• Beef calves vaccinated IFOMA at 10 days old
– MLV/inactivated 4-way (CattleMaster 4®)
– Control group not vaccinated
• At 22 days old
– No difference antibody titers 
– Significantly higher lymphocyte responses to 
IBRV and BRSV in vaccinates
Ellis et al, 1996
• Vaccination IFOMA stimulated specific T 
cells, even though no apparent effect on 
antibody production
Summary
• Vaccination of calves IFOMA can:
– Prime for a memory response after maternal 
antibodies are gone
– Increase the half-life of serum antibodies
– Stimulate T cell responses
• Not as reliable in calves < 1 month old

Vaccination IFOMA and resistance to 
disease
• Increased resistance to disease: best 
measure of value of vaccination IFOMA
• Effect has been measured in response to 
– Experimental challenge
– Naturally-occurring disease
Vaccination IFOMA and 
resistance to disease
• 4 to 6 week old Holsteins
– SN titers 1:4 – 1:64
– “Vaccinated” IN once with MLV (hi pass) BRSV
– Challenged on d. 30 with virulent BRSV 
– Clinical signs evaluated for 7 days
– BRSV-specific IFN-g production in several sites 
evaluated
Woolums et al, 2004

• A single dose of MLV BRSV IN given IFOMA 
protected calves from virulent challenge one 
month later
• Protection was associated with virus-specific 
IFN-g production in respiratory lymph nodes and 
pharyngeal tonsil
• Duration of protection following IN vaccination 
IFOMA may not be long
• This may be particularly true for BRSV
Disease in calves challenged with BRSV after IN 
vaccination IFOMA at 3 – 8 days of age
7 weeks post vac 9 weeks post vac 14 weeks post vac
Ellis et al., 2013

Vaccination IFOMA and resistance to 
disease: BHV-1
• Three separate but related trials: effect if IN vaccination 
on disease due to BHV-1 challenge
– 3 – 8 day old calves
– Trial A and B: calves had no maternal antibody
– Trial C: calves had maternal antibody
• Calves vac IN once with INFORCE 3 (BHV-1, BRSV, PI3V)
• Control calves: same vaccine but no BHV-1
Mahan et al., 2016
Rectal temperatures measured after IBRV challenge
Calves vac IN at 3-8 days of age
A and B: no maternal antibody
C: maternal antibody
Challenged at
1 month after vac (A)
6 months after vac (B)
3 months after vac (C)
Mahan et al., 2016
BHV-1 shedding after BHV-1 challenge
Mahan et al., 
2016
• 5 week old calves
• Fed colostrum with or without BVDV antibody
• Vaccinated MLV adjuvanted 5-way (Pyramid® 5)
• BVDV 2 SN titers at vaccination 1:128 – 1:2048
• Control group: no antibody, no vaccine
• Challenged with BVDV2 at 3.5 months
Zimmerman et al, 2006
Vaccination IFOMA and resistance to 
disease:  BVDV
Zimmerman et al., 2006
NO antibody, vacNO antibody, NO vac antibody, vac
• Calves in the no vac group were positive for 
virus in buffy coats after challenge
– no calves in either vaccinated group was positive 
for virus
• 3 of 7 calves in no vac group died after 
challenge
– No calves in vaccinated groups died 
• Maternal antibody did not prevent the 
development of a protective response to 
vaccination
– Also:  vaccination of 3 – 5 week old seronegative 
calves was safe and effective
• Summary, BVDV studies
– maternal antibody can protect calves from 
virulent BVDV challenge
– calves vaccinated IFOMA develop immunity 
that is protective
• even after maternal antibodies are gone
• Other research:  T cells mediate the immunity 
associated with vaccination when maternal 
antibodies are gone
Endsley et al., 2004
Field Trials
Experimental Challenge Studies
Laboratory Measures of Immunity
Case Studies
Case #1, preweaning beef calves
• 65 head cow-calf 
operation
• BRD in nursing calves 
3 to 4 months old
Case #1, preweaning beef calves
• 30% of calves have signs, 2 
have died
– Necropsy of 1 calf: BRSV 
and Mannheimia
• Three pregnant heifers 




– Dam body condition and nutrition acceptable
– Calving season lasts 5 months
– Cows not vaccinated or dewormed regularly
• vaccinated once 2 years ago with killed 5-way
– Calves not handled until weaning
• Plan to help limit disease in calves now:
– Consider treating all calves in herd with long-acting 
antibiotic 
– OR increase surveillance and treat calves with signs of 
diminished activity
– Vaccination in face of outbreak?
• Often done
• Evidence for benefit anecdotal
• BRSV vac can be harmful in BRSV outbreaks
• Plan to prevent this problem in future:
– Improve maternal antibody to respiratory viruses in 
calves?
• Get cows on annual program of 5-way vaccination
• What about boosting cows late in pregnancy?  
– Can increase antibodies in calves
• Studies have most often tested 2 doses to cows
– Little evidence for decreased disease in calves
• Effect of cow vaccination on preweaning calf BRD
– 430 cows randomly allocated to receive either
• inactivated 5-way viral respiratory
• no vaccine
– cows vaccinated 40 days (mean) from calving
• BRD diagnosed in 12% of calves before weaning
• Incidence of calf BRD not different between groups                     
(OR = 0.8, p = 0.54)
– 13% in calves from unvaccinated dams
– 10% in calves from vaccinated dams
• Trend toward a gender effect seen; heifers from vaccinated dams 
had less BRD (p = 0.07)
Smith et al., 2013
• What about vaccinating the calves?
– MLV best for this application
• Must be safe for use in contact with pregnant cows
• If killed, look for data showing efficacy in animals 
with maternal antibody
– TWO doses ideal
• Consider giving at 2 months and 3 months
– Viral vaccine
• Consider IN first dose, IM second dose
– M. haemolytica vaccine may also help
Case #2: Dairy calves
• Dairy milking 1600 cows
• Pneumonia in calves after they leave hutches and go to group 
pens at 14 days of age
– 18 – 25 calves per group pen
– group pens ≈ 15 feet wide x 30 feet long
– automatic feeder (CF1000, DeLaval)
• Calves are given intranasal IBR/PI3 vaccine at 2 days of age
• Given IM MLV 5-way vaccine immediately before being 
turned into group pens
Case #2: Dairy calves
• 50% of calves treated for pneumonia in past month
• 5 calves out of 200 have died
• Necropsy of 2 calves: pure culture of Histophilus somni








– group sizes 
– group age range
– function of automatic 
feeder
• In both
– timely identification and 
treatment of BRD cases
– consistent adherence to 
treatment protocols
Case #2:  use of vaccines
• Intranasal IBR/PI3 at 1 day of age
• IM 5-way at move to group pens
• Could this approach be improved?  
• What might be better?  
Take home messages:
calf vaccination
• Young calves can respond to immune stimulation
– As early as 1 day of life
– Reliability of response inversely correlated with age
• Especially in calves with good passive transfer




• Passive antibody blocks immune responses 
sometimes but not always
– Blocking greatest in first month of life
– Calves 2 – 3 months old: blocking not much problem




• If vaccinating in first 6 months of life, 2 doses 
advised
– 1 – 2 months between doses




• BRD vaccines must show efficacy in challenge studies to 
be licensed
– But challenge studies are relatively artificial
• Clinical trial evidence supports vaccines for:
– Mannheimia haemolytica
– BRSV
• We need more clinical trials to know how BRD vaccines 
work in “real life”
Take home messages:
BRD vaccination
• When BRD vaccines appear to fail, review factors  related 
to
– vaccine handling
– timing of vaccination
– agents in vaccine vs agents infecting cattle
– ability of host to respond
• Help producers remember that vaccines are just one 
of many management tools needed to prevent BRD

